KOLINPHARMA S.p.A

KOLINPHARMA

E-commerce

I prodotti Kolinpharma

News
News from the world KOLINPHARMA

RITA PAOLA PETRELLI, INTERVIEW FINANCIAL TIMES

12/11/2025 - published at 10.40

Rita Paola Petrelli, interviewed by the Financial Times on the occasion of the 2026 Europe's Long-term Growth Champions award

This moment not only celebrates our journey, but also consolidates our recent prestigious recognition as Europe's Leading Long-Term Growth Company...

EUROPE’S LONG-TERM GROWTH CHAMPIONS

31/10/2025 - published at 12.51

Kolinpharma^® ranks first among European companies in the Health Care & Life Sciences sector in the ranking drawn up by the Financial Times and Statista

We are pleased to share the results of the second edition of the Financial Times and Statista "Europe's Long-term Growth Champions" ranking, which celebrates resilience and innovation in Europe...

20/12/2024 - published at 15.16

KOLINPHARMA® INCLUDED AMONG THE 100 ITALIAN EXCELLENCES

A prestigious recognition for the company

22/05/2024 - published at 13.00

KOLINPHARMA^®: new patent in China for Doltendix®

KOLINPHARMA^® achieved the first patent in China for Doltendix®

29/03/2024 - published at 13.00

KOLINPHARMA^®: has received the prize Credit Reputation Award

20/03/2024 - published at 13.05

KOLINPHARMA^® expands the range of products with the launch of Kymax^®

In recent decades, world demographics have changed significantly with a progressive aging of the global population.

10/01/2024 - published at 13.01

Kolinpharma^® launches KIPFeR^® following agreement with Nemysis LTD

Kipfer is the new dietary supplement designed for all situations in which the body is deficient in iron.

kipfer

09/01/2024 - published at 13.02

Kolinpharma^® is pleased to announce the launch of KIPFeR®

KIPFeR^® is the nanoparticle iron supplement that Kolinpharma^® has launched on the market following a new agreement with Nemysis LTD.

06/03/2023 - published at 15.15

Kolinpharma^® for gender equity a PMIHeroes

Rita Paola Petrelli was being a guest on the podcast PMIHeroes in Ifis Bank

06/12/2022 - published at 15.23

KOLINPHARMA^®: has achieved the first patent for Xinprox^®

Now, Kolinpharma has 46 patents in total

23/11/2022 - published at 15.34

KOLINPHARMA^®: has achieved the award as “Leader of growth 2023” for the fifth consecutive year

Even this year the company is one between 500 Italian enterprises that they were distinguished for the major growth of turnover

25/10/2022 - published at 16.47

KOLINPHARMA^® signs an agreement with ASTAREAL^® AB for distribution in the Asian market

An important three-year agreement for distribution of products in Mainland China, Hong Kong, Macao and Taiwan

05/08/2021 - published at 16.06

Kolinpharma^® at VITAFOODS Europe 2021 in Geneva and at CPHI Worldwide 2021 in Milan

KOLINPHARMA^® strengthens its marketing and brand awareness strategy

16/04/2020 - published at 14.49

KOLINPHARMA^®:first patent for XINEPA^® in Israel and fifth outside Italy

Xinepa^® is a nutraceutical product already in possession of a double patent in Italy

10/03/2020 - published at 16.45

KOLINPHARMA^® obtains the patent in the U.S. of Dolatrox^®

It is the fourth patent that is added to Ivuxur^® and to the 2 of Xinepa^®

Media

Almetax Easy and tablets

Certified products

Company validations

Consumer Protection

Corporate compliance

Profile and organization

Research and development

Respect the environment

Xinepa Easy and tablets

Company profile

Contact media relations

“Science accuracy and listen to people”

“Science accuracy and listen to people”